Key result
CNN-based MRI accurately diagnosed myocardial injury, and Ivabradine combined with Trimetazidine after PCI improved left ventricular function compared to monotherapy.
Why the study?
To evaluate the myocardial protective effects of ivabradine combined with trimetazidine after PCI in CAD patients using CNN-processed MRI images.
Does Ivabradine combined with Trimetazidine improve cardiac function and reduce myocardial injury in patients with CAD after PCI compared to either drug alone?
RCT (n=120)
randomly
Does Ivabradine combined with Trimetazidine improve cardiac function and reduce myocardial injury in patients with CAD after PCI compared to either drug alone?
The combination of ivabradine and trimetazidine after PCI in CAD patients significantly improves cardiac function and reduces myocardial injury and inflammation compared to monotherapy.
Answers are grounded in this paper and cite their sources.
Exploratory CNN-MRI data suggest possible post-PCI myocardial protection with IBD+TMZ; leaves open clinical adoption pending prospective validation.
Objective. To evaluate the myocardial protection of Ivabradine (IBD) combined with Trimetazidine (TMZ) in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI), magnetic resonance imaging (MRI) images under convolutional neural network (CNN) algorithm were used. Methods. A CNN artificial intelligence algorithm was proposed to process the image artifacts caused by undersampling magnetic resonance, so as to be used in the diagnosis and efficacy evaluation of myocardial injury. 120 patients with CAD after PCI were rolled into group A (TMZ treatment), group B (IBD treatment), and group C (IBD + TMZ combined treatment) randomly, with 40 patients in each group. All the patients were treated for two consecutive weeks and followed up for six months. Clinical indicators of patients in the two groups were observed, detected, and statistically analyzed. Results. The accuracy, sensitivity, specificity, and area under the curve (AUC) of MRI images based on CNN algorithm for the diagnosis of myocardial injury were 91.04%, 97.60%, 87.04%, and 96.43%, respectively. After treatment, the left ventricular end diastolic diameter (LVEDD), LVE diastolic volume (LVEDV), LVE systolic diameter (LVESD), and LVE systolic volume (LVESV) were greatly reduced in all groups after treatment, whereas the left ventricular ejection fraction (LVEF) increased considerably ( <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>P</a:mi> <a:mo><</a:mo> <a:mn>0.05</a:mn> </a:math> ). LVEDD, LVEDV, LVESD, and LVESV in group C were substantially inferior to those in groups A and B, and LVEF was remarkably superior to that in groups A and B ( <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>P</c:mi> <c:mo><</c:mo> <c:mn>0.05</c:mn> </c:math> ). After treatment, cTnI, hs-CRP, sICAM-1, ET-1, and MDA in three groups were greatly decreased ( <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>P</e:mi> <e:mo><</e:mo> <e:mn>0.05</e:mn> </e:math> ), while SOD was substantially increased ( <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"> <g:mi>P</g:mi> <g:mo><</g:mo> <g:mn>0.05</g:mn> </g:math> ). After treatment, cTnI, hs-CRP, SICAM-1, ET-1, and MDA in group C were notably inferior to groups A and B ( <i:math xmlns:i="http://www.w3.org/1998/Math/MathML" id="M5"> <i:mi>P</i:mi> <i:mo><</i:mo> <i:mn>0.05</i:mn> </i:math> ), while SOD was greatly higher ( <k:math xmlns:k="http://www.w3.org/1998/Math/MathML" id="M6"> <k:mi>P</k:mi> <k:mo><</k:mo> <k:mn>0.05</k:mn> </k:math> ). Conclusion. MRI based on CNN had high application value in the diagnosis and efficacy evaluation of myocardial injury after PCI. For patients with CAD, IBD combined with TMZ after PCI can effectively play the role of anti-inflammatory and antioxidative damage and improve intradermal function.
No takes yet. Share an insight, caveat, or question.
Chunhua Chen (2021) conducted an RCT in Coronary artery disease after percutaneous coronary intervention (n=120). Ivabradine combined with Trimetazidine vs. Trimetazidine alone or Ivabradine alone was evaluated on Left ventricular function and biomarkers of myocardial injury (p=<0.05). CNN-based MRI accurately diagnosed myocardial injury, and Ivabradine combined with Trimetazidine after PCI improved left ventricular function compared to monotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: